Literature DB >> 17169969

Positron emission tomography in oncology.

Jonathan D Berry1, Gary J R Cook.   

Abstract

Increasing access to positron emission tomography-computed tomography (PET-CT) has resulted in a shift towards functional imaging, being the primary tool in the assessment of viable tumour in oncology patients. In this review, we discuss the basic principles of this evolving technology and the radio-isotopes it employs. The main clinical applications of PET-CT are reviewed and some of the limitations of the technique are highlighted. Finally, we offer insight into possible future developments and how these modify current practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169969     DOI: 10.1093/bmb/ldl013

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  4 in total

1.  Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.

Authors:  Tristan Baguet; Jeroen Verhoeven; Glenn Pauwelyn; Jiyun Hu; Patricia Lambe; Stef De Lombaerde; Sarah Piron; Sam Donche; Benedicte Descamps; Ingeborg Goethals; Christian Vanhove; Filip De Vos; M Hassan Beyzavi
Journal:  Nucl Med Biol       Date:  2020-04-03       Impact factor: 2.408

Review 2.  Advances in Clinical Oncology Research on 99mTc-3PRGD2 SPECT Imaging.

Authors:  Liming Xiao; Jun Xin
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

3.  PET/CT-Guided Interventions in Oncology Patients: A Nursing Perspective.

Authors:  Julia S Taylor; Leah Keller; Majid Maybody
Journal:  J Radiol Nurs       Date:  2017-05-20

4.  Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene.

Authors:  Arnaldur Hall; Kathrine Damm Meyle; Marina Krarup Lange; Martin Klima; May Sanderhoff; Christina Dahl; Cecilie Abildgaard; Katrine Thorup; Seyed Moein Moghimi; Per Bo Jensen; Jiri Bartek; Per Guldberg; Claus Christensen
Journal:  Oncotarget       Date:  2013-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.